Your cart is currently empty!.
You may check out all the available products and buy some in the shop.
Continue Shopping
In Stock
Blends
2X Blend – "Muscle Beach" Tesamorelin 5mg/Ipamorelin 5mg
✓ 99.5% Purity (HPLC)
$100.00
We accept
- Ships within 1–2 business days, discreetly packaged
- Lyophilized for research flexibility
- Third-party HPLC & endotoxin tested per batch
About
What is 2X Blend – "Muscle Beach" Tesamorelin 5mg/Ipamorelin 5mg?
Tesamorelin is a synthetic 44-amino-acid analogue of growth hormone-releasing hormone (GHRH), modified with a trans-3-hexenoic acid group at its N-terminus to extend its plasma half-life versus native GHRH.
Mechanism of Action
Binds to the GHRH receptor on anterior pituitary somatotrophs, stimulating pulsatile endogenous growth hormone release. Research literature describes downstream effects on IGF-1 and lipolysis in adipose tissue.
Discovery & Context
FDA-approved under the brand name Egrifta for HIV-associated lipodystrophy in 2010. Continues to appear in metabolic and body-composition research.
Research use only. Language such as "may," "appears to," and "has been shown in published studies" is used throughout to reflect the pre-clinical nature of this literature. Not intended for human consumption, diagnosis, or treatment.
Background
Research Context
Published research literature covers the following areas:
- Growth-hormone axis research
- Visceral adipose tissue studies
- IGF-1 pathway modulation
- Lipolysis models
- Pituitary physiology
LAR supplies this compound as a reference standard to qualified laboratories. No dosing schedules, administration methods, or human-use guidance is provided or implied.
Literature
Selected References
- Falutz J. et al. (2007). Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials. Journal of Clinical Endocrinology & Metabolism, 92(12), 4291–4304. PubMed 17785365 ↗
- Stanley TL. et al. (2014). Effects of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA, 312(4), 380–389. PubMed 25038357 ↗
Handling
Storage & Stability
Sealed vial: Stable at refrigerated temperatures (2–8 °C) for up to 24 months. Stable at room temperature (up to 25 °C) for 30 days during shipping.
After opening: Refrigerate at 2–8 °C and use within 30 days. Protect from light. Do not freeze after opening.
Visual check: Solution should remain clear. Discard if discoloration or precipitate appears.
Lab Work
Certificate of Analysis
Every batch is independently tested for purity, mass, and endotoxin load. Click any report to view the full analysis.
Questions
Frequently Asked
Is this FDA approved?
No. Research peptides supplied by LAR are reference materials for laboratory investigation. They are not approved by the FDA or any national regulatory body for human use.
Does this vial require reconstitution?
Yes. Vials ship as lyophilized powder, giving your lab control over solvent selection and final concentration. Reconstitution should follow your laboratory's standard practice.
How is purity verified?
Each manufacturing batch is tested by an independent third-party laboratory using HPLC-UV analysis. The full report, including chromatogram and mass spectrometry, is available above.
How long does shipping take?
Orders ship within 1–2 business days via discreet packaging.
